Russia asks India to produce Sputnik V coronavirus vaccine
Bongaigaon: Days after Russia claimed that it has come up with the world's first coronavirus vaccine, the country said that it is looking for partnership with India to produce the coronavirus vaccine named Sputnik V. The decision was formally announced by Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev.
“The production of the vaccine is a very important issue. Currently, we are looking for a partnership with India. We believe that they are capable of producing the Gamaleya vaccine and it is very important to say that those partnerships to produce the vaccine will enable us to cover the demand that we have,” said Dmitriev.
According to media reports, the Sputnik V vaccine is yet to be tested on more than 40,000 people this week in Russia.
Russian President Vladimir Putin on August 11 had announced the world's first coronavirus vaccine made by Russia that works effectively and helps in forming a stable immunity against the virus.
The Sputnik V, developed by Gamaleya Research Institute of Epidemiology and Microbiology along with the RDIF, is yet to undergo phase 3 human trials.
Dmitriev added that several nations around the world have shown interest in the production of the vaccine.
He further said that apart from India, Russia is also looking forward to international cooperation from other countries to speed up the production of Sputnik V so that the pandemic could be brought to an end.